Obesity-a key driver in osteoarthritis
Khaled Elhady Mohamed1,2, Christian S Thudium1, Asger Reinstrup Bihlet3
1Nordic Bioscience, 2730 Herlev, Denmark.
Purpose:
Obesity causes mechanical stress and metabolic dysfunction. However, the relationship between obesity and osteoarthritis (OA) pain still needs further investigation. This study aims to examine the effect of weight loss on pain and function through a secondary analysis of a randomized, double-blind, multicenter OA trial and to evaluate obesity's impact on OA pain using a rat model.
Methods:
In a post hoc analysis of a randomized controlled trial (RCT; NCT00486434), we evaluated baseline body mass index and Western Ontario and McMaster Universities Osteoarthritis (WOMAC) scores (n = 1175) and examined the impact of 5% weight loss on WOMAC scores after 2 years using a factorial analysis of covariance (n = 674). In a preclinical model of metabolic OA induced by meniscectomy, pain-like behavior was assessed with the von Frey and cold plate tests.
Results:
Participants who lost >5% of weight within 2 years experienced a mean decrease of -567.1 (95% CI -666.7 to -467.6) and -399.2 (-505.8 to -292.5) in total WOMAC scores for their target and nontarget knees, respectively, whereas individuals who gained >5% in weight had a smaller decrease of -364.6 (-496.5 to -232.7) and -135 (-277.4 to -6.3), respectively. Additionally, the high-fat diet-fed rat model showed more pain-like behavior than the lean model.
Main Conclusion:
These studies indicate that weight loss could decrease OA pain in both target and nontarget knees of patients with obesity, supporting the inclusion of obesity in OA animal models to improve the translatability of OA treatments.
Related Concept Videos
Obesity
Drug Dosing: Obese Patients
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
